Akoya Biosciences Inc (AKYA)
3.81
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
3.815
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Revenue (TTM): 96.63M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 96.63M |
| September 30, 2023 | 91.36M |
| June 30, 2023 | 85.00M |
| March 31, 2023 | 79.38M |
| December 31, 2022 | 74.86M |
| September 30, 2022 | 69.80M |
| June 30, 2022 | 64.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 59.60M |
| December 31, 2021 | 54.92M |
| September 30, 2021 | 51.67M |
| June 30, 2021 | 48.14M |
| March 31, 2021 | 43.63M |
| December 31, 2020 | 42.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
42.44M
Minimum
Dec 2020
96.63M
Maximum
Dec 2023
66.30M
Average
64.42M
Median
Jun 2022
Revenue (TTM) Benchmarks
| Bruker Corp | 2.964B |
| Azenta Inc | 641.02M |
| Harvard Bioscience Inc | 112.25M |
| Bionano Genomics Inc | 36.12M |
| Singular Genomics Systems Inc | 2.911M |